List of insiders holdings for Sorrento Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GLAUSER STEVEN JERRY 10% Owner | 2008-07-07 17:02:31 | 41,086,194 0 | 41,086,194 | Form 4 |
| SCHUH ANTONIUS Chairman and CEO 10% Owner | 2010-02-18 18:59:56 | 25,634,329 0 | 25,634,329 | Form 4 |
| ZANIBONI STEVE Director 10% Owner | 2010-11-30 12:51:32 | 25,579,329 0 | 25,579,329 | Form 4 |
| Ji Henry See Remarks | 2023-03-20 19:52:53 | 6,265,805 2,331,693 | 8,597,498 | Form 4 |
| ABG Management Ltd ABG II-SO Ltd ABG Innovation-SO Ltd ABG SRNE Ltd Ally Bridge Group Capital Partners II L.P. Ally Bridge Group Innovation Capital Partners III L.P. Ally Bridge LB Healthcare Master Fund Ltd Ally Bridge LB Management Ltd Li Bin Yu Fan 10% Owner | 2020-02-14 06:05:05 | 4,910,374 0 | 4,910,374 | Form 13G |
| SILVER NOAH M VP, Secretary and Treasurer | 2008-07-07 17:05:48 | 4,054,666 0 | 4,054,666 | Form 3 |
| Asia Pacific MedTech (BVI) Ltd Gu Nana 10% Owner | 2021-02-01 16:34:47 | 3,549,074 0 | 3,549,074 | Form 13G |
| SCIFRES DONALD R 10% Owner | 2015-02-17 15:38:55 | 1,753,555 0 | 1,753,555 | Form 13G |
| STEIN RONALD M Director | 2008-07-09 19:14:08 | 1,693,472 0 | 1,693,472 | Form 3 |
| LITTMAN M A Former 10% Owner | 2007-04-04 13:34:49 | 1,500,000 0 | 1,500,000 | Form 4 |
| SOON-SHIONG PATRICK Chan Soon-Shiong Family Foundation Cambridge Equities LP MP 13 Ventures LLC Former 10% Owner | 2016-07-11 18:11:25 | 0 1,224,138 | 1,224,138 | Form 4 |
| HALPRYN GLENN L Director | 2014-03-11 16:05:22 | 803,783 0 | 803,783 | Form 13D |
| Weisberg Alan Jay CFO | 2008-07-08 12:48:33 | 785,925 0 | 785,925 | Form 3 |
| Ng George K See Remarks | 2018-02-28 19:04:44 | 465,615 105,789 | 571,404 | Form 4 |
| Miao Zhenwei SVP, Head of ADC Development | 2015-05-22 16:30:27 | 559,390 0 | 559,390 | Form 4 |
| CZEREPAK ELIZABETH EVP & Chief Financial Officer | 2022-05-20 17:14:46 | 350,000 0 | 350,000 | Form 4 |
| VINCENT RICHARD G See Remarks | 2014-10-09 16:05:22 | 270,000 0 | 270,000 | Form 4 |
| SHAH JAISIM Director | 2021-08-30 20:14:40 | 250,000 0 | 250,000 | Form 4 |
| Wu Yue Alexander Director | 2021-08-30 20:16:20 | 250,000 0 | 250,000 | Form 4 |
| Followwill Dorman Director | 2021-08-30 20:12:02 | 250,000 0 | 250,000 | Form 4 |
| Lemus David Director | 2021-08-30 20:13:44 | 250,000 0 | 250,000 | Form 4 |
| Smith Robin L Director | 2021-09-03 17:36:54 | 235,000 0 | 235,000 | Form 4 |
| Uy George See Remarks | 2015-09-21 20:55:28 | 201,735 0 | 201,735 | Form 4 |
| Marth William S Director | 2016-07-12 17:01:36 | 182,000 0 | 182,000 | Form 4 |
| Royal Mike See Remarks | 2014-10-06 16:05:25 | 160,000 0 | 160,000 | Form 3 |
| Asghar Najjam Chief Financial Officer | 2021-03-17 16:57:12 | 156,974 0 | 156,974 | Form 4 |
| Durand Mark EVP & CFO | 2015-05-01 11:43:57 | 145,000 0 | 145,000 | Form 4 |
| Toledano Miranda Jayne EVP-Corporate Development | 2016-10-05 17:00:42 | 130,000 0 | 130,000 | Form 3 |
| Rodi Charles P VP, Research & Development | 2010-02-09 16:41:48 | 120,000 0 | 120,000 | Form 4 |
| Shao Jiong Chief Financial Officer | 2020-06-15 18:11:07 | 120,000 0 | 120,000 | Form 4 |
| ZELDIS JEROME B See Remarks | 2018-11-27 19:49:49 | 100,000 0 | 100,000 | Form 4 |
| Lee Edgar Director | 2020-06-15 18:09:59 | 100,000 0 | 100,000 | Form 4 |
| Reilly Tammy Director | 2022-05-20 17:11:29 | 100,000 0 | 100,000 | Form 4 |
| EBERSOLE DOUGLAS O Director | 2016-07-12 17:01:29 | 94,000 0 | 94,000 | Form 4 |
| Singh Amar See Remarks | 2014-01-09 17:02:51 | 80,000 0 | 80,000 | Form 3 |
| HSIAO JANE PH D Director | 2012-02-07 18:21:06 | 75,000 0 | 75,000 | Form 4 |
| Ponce Acquisition LLC 10% Owner | 2007-04-05 18:15:41 | 50,000 0 | 50,000 | Form 13D |
| Molsbergen Martina VP, Business Development | 2010-02-09 16:41:16 | 50,000 0 | 50,000 | Form 4 |
| Shuster Lewis Director | 2009-09-23 14:55:22 | 40,000 0 | 40,000 | Form 4 |
| Freedman S. James Director | 2009-09-22 12:21:24 | 40,000 0 | 40,000 | Form 4 |
| Salka Michael Scott Director | 2014-01-24 16:00:34 | 38,000 0 | 38,000 | Form 4 |
| Trieu Vuong CSO Director | 2013-10-31 16:55:12 | 36,000 0 | 36,000 | Form 4 |
| Gallagher Cam Director | 2014-01-24 16:00:32 | 35,000 0 | 35,000 | Form 4 |
| Deming David H Director | 2017-09-18 06:18:21 | 35,000 0 | 35,000 | Form 4/A |
| Webb David Ritchie Director | 2013-10-31 16:50:30 | 29,000 0 | 29,000 | Form 4 |
| AFTING ERNST-GUENTER Director | 2013-10-31 16:56:11 | 26,600 0 | 26,600 | Form 4 |
| Tang-Liu Diane D S Director | 2012-07-20 19:51:24 | 15,000 0 | 15,000 | Form 4 |
| Lockshin Curtis Director | 2012-07-20 19:37:30 | 15,000 0 | 15,000 | Form 4 |
| LEVITT DANIEL J Director | 2014-02-03 15:28:43 | 13,000 0 | 13,000 | Form 3 |
| Su Jeffrey Executive VP and COO | 2017-02-03 19:49:24 | 13,000 0 | 13,000 | Form 4 |
| Herde Kevin Executive VP and CFO | 2017-02-03 19:48:23 | 7,000 0 | 7,000 | Form 4 |
| Ferrigno Dean Chief Accounting Officer | 2018-02-28 19:05:01 | 363 0 | 363 | Form 4 |
| Opko Health Inc. 10% Owner | 2019-05-09 17:14:03 | 0 0 | 0 | Form 13D |
| KEATING KEVIN R See Remarks | 2008-07-09 16:00:31 | 0 0 | 0 | Form 4 |
| KI EQUITY PARTNERS V LLC See Remarks | 2008-07-09 15:58:59 | 0 0 | 0 | Form 4 |
| ANDREWS JEFF L Director | 2007-03-26 13:12:04 | 0 0 | 0 | Form 3 |
| BLACKWELL MARGIE L Director | 2007-03-26 13:10:29 | 0 0 | 0 | Form 3 |
| WHITING WESLEY F Director | 2007-02-22 16:40:26 | 0 0 | 0 | Form 3 |
| Janda Kim Director | 2023-02-06 21:10:05 | 0 0 | 0 | Form 5 |
| Green Redgie T Director | 2007-02-22 16:37:19 | 0 0 | 0 | Form 3 |